ENRIQUE FERNANDEZ

Allopathic & Osteopathic Physicians|Family Medicine MIAMI, FL NPI 1528040086

General Payments — all program years on this page

$13,519.45

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 233
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $781.98 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $5,846.9457
2019 $4,160.9346
2020 $212.5413
2021 $501.6332
2022 $603.8244
2023 $1,411.6121
2024 $781.9820

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086942237 Novartis Pharmaceuticals Corporation $22.25 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086942243 Novartis Pharmaceuticals Corporation $27.69 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101313965 E.R. Squibb & Sons, L.L.C. $14.67 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101313995 E.R. Squibb & Sons, L.L.C. $28.30 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104217997 AstraZeneca Pharmaceuticals LP $18.26 02/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105589256 AstraZeneca Pharmaceuticals LP $21.78 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105748435 AstraZeneca Pharmaceuticals LP $34.32 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111574118 Amgen Inc. $9.64 09/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111574120 Amgen Inc. $400.00 03/14/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1114656026 Exact Sciences Corporation $17.85 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114656032 Exact Sciences Corporation $21.03 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114656038 Exact Sciences Corporation $20.60 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116518250 GlaxoSmithKline, LLC. $15.93 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116712943 GlaxoSmithKline, LLC. $17.70 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118044320 Boehringer Ingelheim Pharmaceuticals, Inc. $19.93 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134972623 Lilly USA, LLC $20.95 06/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136169599 Lilly USA, LLC $17.20 02/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139279756 Astellas Pharma US Inc $17.90 01/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146780821 IDORSIA PHARMACEUTICALS US INC $19.08 06/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151060767 Phathom Pharmaceuticals, Inc. $16.90 03/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.